What to know
- CDC collects and analyzes data from several public health surveys to monitor the prevalence of Long COVID and symptoms among children and adults.
- Continued study of Long COVID improves understanding and informs public health and clinical strategies to prevent and reduce the impacts of Long COVID.
- Updates for estimated prevalence of Long COVID by demographics and by state and jurisdiction are anticipated by June 30 and December 31, 2026, respectively.
Long COVID in the U.S.
Estimates of Long COVID vary due to different study designs, symptoms investigated, patient populations, and timing of when symptoms are assessed. CDC collects and analyzes data about Long COVID through several public health surveys. Long COVID estimates reported on this page are based on a standard question for self-reporting of ongoing symptoms or using electronic health records to identify new conditions. 123 Currently, there is no specific diagnostic test to determine if a person is experiencing Long COVID.
By State
Long COVID prevalence differs by state and region in the United States.
How to use this dashboard
1. Select a filter of interest
Data presented on the prevalence of Long COVID by U.S. state is color-coded to better distinguish between the prevalence estimates across the country; darker shades of orange indicate higher prevalence estimates whereas the lighter shade of orange represents states with lower estimates.
2. Select different ways to view the data
States and territories are listed and may be selected alphabetically or by prevalence of Long COVID. You can select a specific state or territory by clicking on the state in the alphabetical list or on the map itself.
By Demographics
How to use this dashboard
1. Select a filter of interest
Filters that may be used at one time vary by topic. Topics may be filtered by data collection year, Long COVID status (such as whether the individual is currently experiencing Long COVID), and age group (pediatric or adult) using the buttons to the left of each dashboard.
2. Select different ways to view the data
Hovering your mouse over any data point or line in the graphs will display detailed information.
New Conditions and Symptoms Following COVID-19
Long COVID includes newly diagnosed conditions and symptoms following a SARS-CoV-2 infection. Estimates of newly diagnosed conditions from CDC's Track PCC project show the highest incidence of new conditions in the first 3 months after SARS-CoV-2 infection and that new conditions continue to occur for 12 months.
How to use this dashboard
1. Select a filter of interest
Data on the incidence of new conditions or symptoms following COVID-19 diagnosis can be viewed by year and age group.
2. Select different ways to view the data
Hovering your mouse over any data point or line in the graphs will display detailed information.
Prevention
COVID-19 vaccines reduce the risk of Long COVID. Research shows that getting a COVID-19 vaccine reduces the risk of developing Long COVID among both children and adults. 456
- Ford ND, Agedew A, et al. Notes from the Field: Long COVID and Significant Long COVID–Associated Activity Limitation Among Adults, by Jurisdiction — United States, 2023. MMWR Morb Mortal Wkly Rep 2024;73:1142–1143. DOI: http://dx.doi.org/10.15585/mmwr.mm7350a2.
- Ford ND, Vahratian A, Pratt CQ, et al. Long COVID Prevalence and Associated Activity Limitation in US Children. JAMA Pediatr. 2025;179(4):471–473. doi:10.1001/jamapediatrics.2024.6206
- Vahratian A, Saydah S, Bertolli J, Unger ER, Gregory CO. Prevalence of Post–COVID-19 Condition and Activity-Limiting Post–COVID-19 Condition Among Adults. JAMA Netw Open. 2024;7(12):e2451151. doi:10.1001/jamanetworkopen.2024.51151
- Razzaghi H, Forrest CB, Hirabayashi K et al. RECOVER CONSORTIUM. Vaccine Effectiveness Against Long COVID in Children. Pediatrics. 2024 Apr 1;153(4):e2023064446. doi:1542/peds.2023-064446.
- Watanabe A, Iwagami M, Yasuhara J, et al. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023 Mar 10;41(11):1783-1790. Epub 2023 Feb 8. doi: 1016/j.vaccine.2023.02.008.
- Malden DE, Liu IA, Qian L, et al. Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection. Nat Commun. 2024 May 22;15(1):4101. doi: 1038/s41467-024-48022-9.